chinapharmaholdings.com (CPHI) - Koefisien utang jangka dawa marang modal

The market trend for China Pharma Holdings (CPHI), which specializes in mental health pharmaceuticals, stands at 0.00. This price action reflects strict government price regulations and intense competition among Chinese manufacturers. Declining profitability is driven by a lack of patent protection and pressure from government procurement programs. Business stability is based on the company's share of generics in China, GMP compliance, and the supply of medications for infections and liver diseases.

Developing innovative drugs for the treatment of CNS and infections in Asia requires significant capital expenditures. This indicator compares obligations with a maturity of over one year to the net assets of the owners. It measures the degree of financial leverage, determining the extent to which business development depends on borrowed funds. A low ratio confirms stability but may indicate an underutilization of credit potential. By analyzing the structure of long-term debt relative to equity, an investor assesses the balance between risk and profitability for China Pharma Holdings (CPHI).